Xcovery

FL - Miami

Biotechnology

Website LinkedIn Careers Page

Focus: Targeted cancer therapeutics

Xcovery is a life sciences company focused on Targeted cancer therapeutics.

Oncology

Open Jobs

0

Products & Portfolio (1)

SMORAL · CAPSULE

(ALK) and inhibits other kinases including MET and ROS1. In vitro, ensartinib inhibited phosphorylation of ALK and its downstream signaling proteins AKT, ERK, and S6, thereby blocking ALK-mediated signaling pathways and inhibiting proliferation in cell lines harboring ALK fusions and mutations. In vivo, ensartinib showed anti-tumor activity in a mouse xenograft model of human NSCLC harboring an ALK fusion.

metastatic non-small cell lung cancer (NSCLC)lung cancerlymphoma

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Portfolio: 1 approved product

Top TAs: Oncology

Portfolio Health

Growth1 (100%)

1 total products

Therapeutic Area Focus

1 marketed

Marketed

Pipeline